Petros Pharmaceuticals Company Top Insiders

Petros Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.3061) % which means that it has lost $0.3061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6377) %, meaning that it created substantial loss on money invested by shareholders. Petros Pharmaceuticals' management efficiency ratios could be used to measure how well Petros Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.35. The current Return On Capital Employed is estimated to decrease to -0.62. As of now, Petros Pharmaceuticals' Non Current Assets Total are decreasing as compared to previous years. The Petros Pharmaceuticals' current Non Currrent Assets Other is estimated to increase to about 6.2 M, while Other Assets are projected to decrease to under 9.4 M. The current Common Stock Shares Outstanding is estimated to decrease to about 1.4 M. The current Net Loss is estimated to decrease to about (10.9 M)

Petros Pharmaceuticals Workforce Comparison

Petros Pharmaceuticals Profit Margins

The company has Profit Margin (PM) of (1.71) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.6.

Petros Pharmaceuticals Insider Trading

Petros Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Petros Pharmaceuticals often depends on how effective the management is. Petros Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Petros management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Petros management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Petros Pharmaceuticals' price analysis, check to measure Petros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petros Pharmaceuticals is operating at the current time. Most of Petros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.